Online ISSN: 2515-8260

Keywords : Cardiovascular


An Observational Study Of Cardiovascular Outcome In Patients Undergoing Primary Pci With Indian Manufactured Des

Dr. Pragathi Gurram; Dr. Suresh Yerra

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 6795-6811

Background: Raising cardiovascular diseases and its associated comorbidity, health risks and consequences carry a massive health care system and economic burden on the society. Aim: To compare the different Indian manufactured drug eluting stents (DES) in patients undergoing primary percutaneous coronary intervention (PCI) with primary objective of major adverse cardiac and cerebrovascular events (MACCE). Study design: Observational, retrospective, and prospective study. Methodology: Study conducted at Sunshine Heart Institute from Jan 2016 to April 2018 in all the patients who have undergone primary PCI with Indian manufactured DES. The baseline clinical, procedural, in-hospital data and follow-up data was taken at 01, 03, 06 and 12 months, till end of study period at regular intervals, after the index procedure. Results: 163 patients were considered for the data analysis in 3 groups i.e. Premier (51), Tetrilimus (47) & YCF (65). Conclusion: All the three study groups have shown similar primary and secondary outcomes. However, further studies are required on large scale for accurate assessment and evaluation.

The Advent of Artificial Intelligence in Cardiology: The Current Applications and Future Prospects

K Prashanth; M Manjappa; C Srikar

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 14-20

The technology of artificial intelligence is emerging as a promising entity in cardiovascular medicine, with the potential to improve diagnosis and patient care. In this article we review the literature on artificial intelligence and its utility in cardiology. We provide a detailed description of concepts of artificial intelligence tools like machine learning, deep learning and cognitive computing. This review discusses the current evidence, applications, future prospects and limitations of artificial intelligence in cardiology.

The COVID-19 Pandemic and Impact on the Cardiovascular Disease Patient: Special Emphasis on Rheumatic Valvular Heart Disease Care

K Prashanth; M Manjappa; A Srinivas

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 10-13

The COVID-19 crisis has surged worldwide putting immense stress on the health care services, leading to institutions deferring elective procedures and struggling to triage the emergency care of the cardiac patient. This has affected the management of the rheumatic valvular heart disease patient especially in Asia and other developing countries, potentially placing these patients at enormous risk for complications like congestive cardiac failure, stroke and death. In this current review, we explore the COVID-19 pandemic and its impact on the cardiovascular disease patient with special emphasis on rheumatic valvular heart disease care. We try to provide a framework that address the procedural considerations of interventions like percutaneous transluminal mitral commissurotomy (PTMC) and mitral and aortic valve surgeries. We also highlight the implications for the outpatient valve clinic and address the safety issues of the patient and health care workers during this on-going COVID-19 pandemic.